Free hemoglobin determination at patients' bedside to evaluate hemolysis.
Bastien BaudAnne Marie DupuySamuel ZozorStephanie BadiouAnne Sophie BargnouxOlivier MathieuJean-Paul CristolPublished in: Bioanalysis (2023)
Background: The authors report the relevance of using a point of care test (Helge ® ) for free hemoglobin determination and concordance of the values the with Cobas ® 8000 and spectrophotometer methods. Results: The within-run of the point of care test was <3%. Good correlations among the three methods were observed and an acceptable concordance for hemolysis index values from 50 mg/dl. An excellent agreement between the Cobas 8000 and the spectrophotometer was found. Conclusion: Automated methods represent methods of choice for free hemoglobin determination. An advantage of the Helge system is that it can be applied to samples experiencing a delay in evaluation due to the long distance between the collection site and the central laboratory. Another advantage is its use at the bedside, in the monitoring of extracorporeal membrane oxygenation patients.
Keyphrases
- extracorporeal membrane oxygenation
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- red blood cell
- acute respiratory distress syndrome
- peritoneal dialysis
- machine learning
- solid phase extraction
- molecularly imprinted
- intensive care unit
- deep learning
- patient reported outcomes
- high resolution
- decision making